Enova chair Fisher exercises, sells 20,750 shares
Enova International’s executive chairman exercised 20,750 options and sold the resulting shares under a pre-arranged Rule 10b5-1 trading plan.
Rhea-AI Filing Summary
Enova International, Inc. (ENVA) reported that Executive Chairman David Fisher exercised stock options for 20,750 shares of common stock on September 17, 2026 at an exercise price of $20.73 per share, converting a tandem non-qualified stock option with a limited stock appreciation right into common stock.
On the same date, Fisher sold 20,750 shares of common stock at a weighted average price of $178.2377 per share under a Rule 10b5-1 trading plan adopted on January 30, 2026. Following the option exercise, he held 145,363 derivative securities (options) directly.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Exercise and sale activity reported; no spread calculated
Exercise and Sale
3 txns
Insider
Fisher David
Role
Executive Chairman
Sold
20,750 shs ($3.70M)
Approx. gross sale proceeds
$3.70M
Approx. exercise cost
$430K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Non-Qualified Stock Option (right to buy) with limited SAR F3, F4, F5 | 20,750 | $0.00 | $0.00 |
| Exercise | Common stock, par value $0.00001 per share | 20,750 | $20.73 | $430K |
| Sale | Common stock, par value $0.00001 per share F1, F2 | 20,750 | $178.2377 | $3.70M |
Holdings After Transaction:
Non-Qualified Stock Option (right to buy) with limited SAR — 145,363 contracts (Direct);
Common stock, par value $0.00001 per share — 306,444 shares (Direct)
Footnotes (5)
- F1. The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan adopted on January 30, 2026.
- F2. This transaction was executed in multiple trades at prices ranging from $174.55 to $180.00. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer full information regarding the number of shares and the prices at which the transaction was effected.
- F3. The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made.
- F4. The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer.
- F5. The options vested in substantially equal one-third increments on each of the following dates: February 11, 2021, February 11, 2022, and February 11, 2023.
Key Figures
Options exercised: 20,750 shares
Option exercise price: $20.73 per share
Shares sold: 20,750 shares
+4 more
7 metrics
Options exercised
20,750 shares
Non-qualified stock options with limited SAR exercised on September 17, 2026
Option exercise price
$20.73 per share
Exercise price for 20,750 options converted into common stock
Shares sold
20,750 shares
Common stock sold on September 17, 2026 following option exercise
Weighted average sale price
$178.2377 per share
Weighted average for sales executed between $174.55 and $180.00
Remaining derivative securities
145,363 options
Derivative securities held directly by David Fisher after the reported exercise
Rule 10b5-1 plan adoption date
January 30, 2026
Date Fisher’s trading plan governing the reported sale was adopted
Option vesting dates
February 11, 2021; February 11, 2022; February 11, 2023
Three substantially equal one-third vesting increments for the exercised options
Key Terms
Rule 10b5-1 trading plan, limited stock appreciation right ("SAR"), Change in Control, Offer Value Per Share, +1 more
5 terms
Rule 10b5-1 trading plan regulatory
"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
limited stock appreciation right ("SAR") financial
"The limited stock appreciation right ("SAR") and employee stock option were granted"
Change in Control financial
"The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control""
A "change in control" occurs when the ownership or management of a company shifts significantly, such as through a merger, acquisition, or sale of a large part of its assets. This change can impact how the company is run and may influence its future direction. For investors, it matters because it can affect the company's stability, strategy, and value, often signaling potential changes in investment risk or opportunity.
tender offer or exchange offer regulatory
""Offer" means any tender offer or exchange offer for outstanding shares of Issuer"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Enova International (ENVA) disclose about David Fisher’s recent equity transactions?
Enova International reported that Executive Chairman David Fisher exercised 20,750 stock options at $20.73 per share on September 17, 2026 and sold 20,750 common shares the same day at a weighted average price of $178.2377 per share.
How many ENVA options did David Fisher exercise and at what price?
David Fisher exercised 20,750 non-qualified stock options on September 17, 2026 at an exercise price of $20.73 per share, receiving an equivalent number of Enova International common shares.
How many Enova International derivative securities does David Fisher hold after these transactions?
After exercising options, David Fisher directly held 145,363 derivative securities (stock options) of Enova International, as reported in the Form 4 data for the option position following the transaction.
What are the vesting dates of the Enova International options David Fisher exercised?
A footnote explains the options vested in substantially equal one-third increments on February 11, 2021, February 11, 2022, and February 11, 2023 before being exercised on September 17, 2026.
AI-generated analysis. How Rhea-AI works. Not financial advice.
